ANXA6 and coronary artery disorder: Conversely, Song et al. found that the expression of annexin A6 was markedly reduced at the mRNA and protein level in end-stage human hearts failing due to coronary artery disease (n = 6) or idiopathic DCM (n = 6) compared with controls (n = 6) (67).